| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sara V Carlini, Teresa Lanza di Scalea, Stephanie Trentacoste McNally, Janice Lester, Kristina M Deligiannidi. Management of Premenstrual Dysphoric Disorder: A Scoping Review. Focus (American Psychiatric Publishing). vol 22. issue 1. 2024-05-02. PMID:38694162. |
premenstrual dysphoric disorder (pmdd) and premenstrual syndrome (pms) refer to physical, cognitive, or affective symptoms that arise in the late luteal phase and remit with menses. |
2024-05-02 |
2024-05-04 |
Not clear |
| Julianna Prim, Oleg Favorov, Jolie Jeffrey, Susan Girdler, Crystal Schille. Objective Smartwatch Indices of Affective Switching: A Pilot Study in Premenstrual Dysphoric Disorder. Studies in health technology and informatics. vol 310. 2024-01-25. PMID:38269738. |
objective smartwatch indices of affective switching: a pilot study in premenstrual dysphoric disorder. |
2024-01-25 |
2024-01-27 |
Not clear |
| Julianna Prim, Oleg Favorov, Jolie Jeffrey, Susan Girdler, Crystal Schille. Objective Smartwatch Indices of Affective Switching: A Pilot Study in Premenstrual Dysphoric Disorder. Studies in health technology and informatics. vol 310. 2024-01-25. PMID:38269738. |
to model affective switching, we studied premenstrual dysphoric disorder (pmdd): a depressive disorder with a regularly occurring monthly trigger. |
2024-01-25 |
2024-01-27 |
Not clear |
| Ajna Hamidovic, Shahd Smadi, John Davi. Late Luteal Subphase Food Craving Is Enhanced in Women with Obesity and Premenstrual Dysphoric Disorder (PMDD). Nutrients. vol 15. issue 23. 2023-12-09. PMID:38068858. |
to identify novel targets for enhancing the efficacy of weight loss interventions, we examined whether food craving varies across the menstrual cycle according to the abdominal obesity type and premenstrual dysphoric disorder (pmdd) diagnosis, and, if so, whether it is related to affective symptomatology. |
2023-12-09 |
2023-12-17 |
human |
| Madhura Dixit Vinchurney, Mrunali D Dhokne, Nandkishor Kotagale, Milind J Umekar, Brijesh Taksand. Agmatine prevents the manifestation of impulsive burying and depression-like behaviour in progesterone withdrawn female rats. Hormones and behavior. vol 152. 2023-05-10. PMID:37163843. |
premenstrual dysphoric disorder (pmdd) is characterized by various physical and affective symptoms, including anxiety, irritability, anhedonia, social withdrawal, and depression. |
2023-05-10 |
2023-08-14 |
rat |
| Liisa Hantsoo, Jennifer L Payn. Towards Understanding the Biology of Premenstrual Dysphoric Disorder: From Genes to GABA. Neuroscience and biobehavioral reviews. 2023-04-14. PMID:37059403. |
premenstrual dysphoric disorder (pmdd) is a severe mood disorder, with affective, symptoms that rise and fall in concert with the hormonal fluctuations of the menstrual. |
2023-04-14 |
2023-08-14 |
Not clear |
| Inbal Reuveni, Rotem Dan, Laura Canetti, Atira S Bick, Ronen Segman, Moria Azoulay, Carmel Kalla, Omer Bonne, Gadi Goelma. Aberrant Intrinsic Brain Network Functional Connectivity in Women Diagnosed with Premenstrual Dysphoric Disorder During Face-Matching Task. Biological psychiatry. 2023-04-09. PMID:37031779. |
premenstrual dysphoric disorder (pmdd) is characterized by affective, cognitive and physical symptoms, suggesting alterations at the brain-network level. |
2023-04-09 |
2023-08-14 |
Not clear |
| Ajna Hamidovic, John Davis, Fatimata Soumare, Aamina Naveed, Yaseen Ghani, Selma Semiz, Dina Khalil, Margaret Wardl. Allopregnanolone Is Associated with a Stress-Induced Reduction of Heart Rate Variability in Premenstrual Dysphoric Disorder. Journal of clinical medicine. vol 12. issue 4. 2023-02-25. PMID:36836088. |
during stress, a greater disinhibition of the vagal nerve is reflective of poor stress adaptability, which may be relevant in premenstrual dysphoric disorder (pmdd)-a debilitating affective condition thought to be marked by dysregulated stress processing and sensitivity to allopregnanolone. |
2023-02-25 |
2023-08-14 |
human |
| Sara V Carlini, Teresa Lanza di Scalea, Stephanie Trentacoste McNally, Janice Lester, Kristina M Deligiannidi. Management of Premenstrual Dysphoric Disorder: A Scoping Review. International journal of women's health. vol 14. 2022-12-28. PMID:36575726. |
premenstrual dysphoric disorder (pmdd) and premenstrual syndrome (pms) refer to physical, cognitive, or affective symptoms that arise in the late luteal phase and remit with menses. |
2022-12-28 |
2023-08-14 |
Not clear |
| Lara Tiranini, Rossella E Napp. Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome. Faculty reviews. vol 11. 2022-05-16. PMID:35574174. |
premenstrual syndrome (pms) and premenstrual dysphoric disorder (pmdd) are common disorders of the luteal phase of the menstrual cycle and are characterized by moderate to severe physical, affective, or behavioral symptoms that impair daily activities and quality of life. |
2022-05-16 |
2023-08-13 |
Not clear |
| Manon Dubol, Johan Wikström, Rupert Lanzenberger, C Neill Epperson, Inger Sundström-Poromaa, Erika Comasc. Grey matter correlates of affective and somatic symptoms of premenstrual dysphoric disorder. Scientific reports. vol 12. issue 1. 2022-04-10. PMID:35397641. |
grey matter correlates of affective and somatic symptoms of premenstrual dysphoric disorder. |
2022-04-10 |
2023-08-13 |
Not clear |
| Theresa Beddig, Iris Reinhard, Ulrich Ebner-Priemer, Christine Kuehne. Reciprocal effects between cognitive and affective states in women with Premenstrual Dysphoric Disorder: An Ecological Momentary Assessment study. Behaviour research and therapy. vol 131. 2021-10-19. PMID:32497737. |
reciprocal effects between cognitive and affective states in women with premenstrual dysphoric disorder: an ecological momentary assessment study. |
2021-10-19 |
2023-08-13 |
Not clear |
| Liisa Hantsoo, Christian Grillon, Mary Sammel, Rachel Johnson, Joanna Marks, C Neill Epperso. Response to sertraline is associated with reduction in anxiety-potentiated startle in premenstrual dysphoric disorder. Psychopharmacology. vol 238. issue 10. 2021-10-15. PMID:34292344. |
women with premenstrual dysphoric disorder (pmdd) appear to have altered central nervous system sensitivity to neuroactive steroid hormones, manifesting as affective symptoms and heightened arousal in the luteal phase of the menstrual cycle. |
2021-10-15 |
2023-08-13 |
Not clear |
| Jing Wang, Antao Che. High progesterone levels facilitate women's social information processing by optimizing attention allocation. Psychoneuroendocrinology. vol 122. 2021-08-30. PMID:33068952. |
moreover, overactivation of the social monitoring system may make women more susceptible to stressors and promote affective disturbances, which may provide underlying pathophysiology of the premenstrual dysphoric disorder. |
2021-08-30 |
2023-08-13 |
Not clear |
| Elisavet Kaltsouni, Patrick M Fisher, Manon Dubol, Steinar Hustad, Rupert Lanzenberger, Vibe G Frokjaer, Johan Wikström, Erika Comasco, Inger Sundström-Poroma. Brain reactivity during aggressive response in women with premenstrual dysphoric disorder treated with a selective progesterone receptor modulator. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 46. issue 8. 2021-06-28. PMID:33927343. |
premenstrual dysphoric disorder (pmdd) is a psychiatric condition characterized by late luteal phase affective, cognitive, and physical impairment. |
2021-06-28 |
2023-08-13 |
Not clear |
| Manon Dubol, C Neill Epperson, Rupert Lanzenberger, Inger Sundström-Poromaa, Erika Comasc. Neuroimaging premenstrual dysphoric disorder: A systematic and critical review. Frontiers in neuroendocrinology. vol 57. 2021-05-24. PMID:32268180. |
endocrine organizational and activational influences on cognitive and affective circuits are likely critical to the development of premenstrual dysphoric disorder (pmdd), a sex-specific hormone-dependent mood disorder. |
2021-05-24 |
2023-08-13 |
human |
| Erika Comasco, Helena Kopp Kallner, Marie Bixo, Angelica L Hirschberg, Sara Nyback, Haro de Grauw, C Neill Epperson, Inger Sundström-Poroma. Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial. The American journal of psychiatry. vol 178. issue 3. 2021-03-22. PMID:33297719. |
premenstrual dysphoric disorder (pmdd) is a common mood disorder, characterized by distressing affective, behavioral, and somatic symptoms in the late luteal phase of the menstrual cycle. |
2021-03-22 |
2023-08-13 |
Not clear |
| Liisa Hantsoo, C Neill Epperso. Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiology of stress. vol 12. 2020-09-28. PMID:32435664. |
premenstrual dysphoric disorder (pmdd) is a severe mood disorder with core symptoms (affective lability, irritability, depressed mood, anxiety) and increased sensitivity to stress occurring in the luteal phase of the menstrual cycle. |
2020-09-28 |
2023-08-13 |
Not clear |
| Ju-Yu Yen, Pai-Cheng Lin, Mei-Feng Huang, Wei-Po Chou, Cheng-Yu Long, Chih-Hung K. Association between Generalized Anxiety Disorder and Premenstrual Dysphoric Disorder in a Diagnostic Interviewing Study. International journal of environmental research and public health. vol 17. issue 3. 2020-08-24. PMID:32033286. |
premenstrual dysphoric disorder (pmdd) demonstrates predictable, cyclic, affective and somatic symptoms that are aggravated in the late luteal phase and are resolved by menstruation. |
2020-08-24 |
2023-08-13 |
Not clear |
| Kristian Høj Reveles Jensen, Karen Sinclai. [Premenstrual dysphoric disorder is often overlooked]. Ugeskrift for laeger. vol 180. issue 47. 2020-01-27. PMID:30509347. |
premenstrual dysphoric disorder (pmdd) is a cluster of severe affective symptoms recurring during the luteal phase of the menstrual cycle, and it affects up to 8% of menstruating women. |
2020-01-27 |
2023-08-13 |
Not clear |